Global Flu Vaccine Market Outlook 2022

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).

The global Flu Vaccine market was valued at US$ 5154 million in 2020 and is expected to reach US$ 7293.3 million by the end of 2027, growing at a CAGR of 4.8% during 2021-2027.

This report focuses on Flu Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Flu Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Flu Vaccine Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

For Children (6 months to 3 years)

For Adults and Children over 3 years

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Sanofi Pasteur

CSL

GSK

Mylan

Hulan Bio

AstraZeneca

CCBIO

1.1 Product Overview and Scope of Flu Vaccine

1.2 Flu Vaccine Segment by Type

1.2.1 Global Flu Vaccine Sales Growth Rate Comparison by Type (2021-2027)

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Flu Vaccine Segment by Application

1.3.1 Global Flu Vaccine Sales Comparison by Application: (2021-2027)

1.3.2 For Children (6 months to 3 years)

1.3.3 For Adults and Children over 3 years

1.4 Global Flu Vaccine Market Size Estimates and Forecasts

1.4.1 Global Flu Vaccine Revenue 2016-2027

1.4.2 Global Flu Vaccine Sales 2016-2027

1.4.3 Flu Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2.1 Global Flu Vaccine Sales Market Share by Manufacturers (2016-2021)

2.2 Global Flu Vaccine Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Flu Vaccine Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Flu Vaccine Manufacturing Sites, Area Served, Product Type

2.5 Flu Vaccine Market Competitive Situation and Trends

2.5.1 Flu Vaccine Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Flu Vaccine Players Market Share by Revenue

2.5.3 Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Flu Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021

3.2 Global Flu Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021

3.3 North America Flu Vaccine Market Facts & Figures by Country

3.3.1 North America Flu Vaccine Sales by Country

3.3.2 North America Flu Vaccine Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Flu Vaccine Market Facts & Figures by Country

3.4.1 Europe Flu Vaccine Sales by Country

3.4.2 Europe Flu Vaccine Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Flu Vaccine Market Facts & Figures by Region

3.5.1 Asia Pacific Flu Vaccine Sales by Region

3.5.2 Asia Pacific Flu Vaccine Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Flu Vaccine Market Facts & Figures by Country

3.6.1 Latin America Flu Vaccine Sales by Country

3.6.2 Latin America Flu Vaccine Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Flu Vaccine Market Facts & Figures by Country

3.7.1 Middle East and Africa Flu Vaccine Sales by Country

3.7.2 Middle East and Africa Flu Vaccine Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4.1 Global Flu Vaccine Sales Market Share by Type (2016-2021)

4.2 Global Flu Vaccine Revenue Market Share by Type (2016-2021)

4.3 Global Flu Vaccine Price by Type (2016-2021)

5.1 Global Flu Vaccine Sales Market Share by Application (2016-2021)

5.2 Global Flu Vaccine Revenue Market Share by Application (2016-2021)

5.3 Global Flu Vaccine Price by Application (2016-2021)

6.1 Sanofi Pasteur

6.1.1 Sanofi Pasteur Corporation Information

6.1.2 Sanofi Pasteur Description and Business Overview

6.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)

6.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio

6.1.5 Sanofi Pasteur Recent Developments/Updates

6.2 CSL

6.2.1 CSL Corporation Information

6.2.2 CSL Description and Business Overview

6.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)

6.2.4 CSL Flu Vaccine Product Portfolio

6.2.5 CSL Recent Developments/Updates

6.3 GSK

6.3.1 GSK Corporation Information

6.3.2 GSK Description and Business Overview

6.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)

6.3.4 GSK Flu Vaccine Product Portfolio

6.3.5 GSK Recent Developments/Updates

6.4 Mylan

6.4.1 Mylan Corporation Information

6.4.2 Mylan Description and Business Overview

6.4.3 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)

6.4.4 Mylan Flu Vaccine Product Portfolio

6.4.5 Mylan Recent Developments/Updates

6.5 Hulan Bio

6.5.1 Hulan Bio Corporation Information

6.5.2 Hulan Bio Description and Business Overview

6.5.3 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)

6.5.4 Hulan Bio Flu Vaccine Product Portfolio

6.5.5 Hulan Bio Recent Developments/Updates

6.6 AstraZeneca

6.6.1 AstraZeneca Corporation Information

6.6.2 AstraZeneca Description and Business Overview

6.6.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)

6.6.4 AstraZeneca Flu Vaccine Product Portfolio

6.6.5 AstraZeneca Recent Developments/Updates

6.7 CCBIO

6.6.1 CCBIO Corporation Information

6.6.2 CCBIO Description and Business Overview

6.6.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)

6.4.4 CCBIO Flu Vaccine Product Portfolio

6.7.5 CCBIO Recent Developments/Updates

7.1 Flu Vaccine Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Flu Vaccine

7.4 Flu Vaccine Industrial Chain Analysis

8.1 Marketing Channel

8.2 Flu Vaccine Distributors List

8.3 Flu Vaccine Customers

9.1 Flu Vaccine Industry Trends

9.2 Flu Vaccine Growth Drivers

9.3 Flu Vaccine Market Challenges

9.4 Flu Vaccine Market Restraints

10.1 Flu Vaccine Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Flu Vaccine by Type (2022-2027)

10.1.2 Global Forecasted Revenue of Flu Vaccine by Type (2022-2027)

10.2 Flu Vaccine Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Flu Vaccine by Application (2022-2027)

10.2.2 Global Forecasted Revenue of Flu Vaccine by Application (2022-2027)

10.3 Flu Vaccine Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Flu Vaccine by Region (2022-2027)

10.3.2 Global Forecasted Revenue of Flu Vaccine by Region (2022-2027)

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

List of Tables

    Table 1. Global Flu Vaccine Sales (M Doses) Growth Rate Comparison by Type (2021-2027)

    Table 2. Global Flu Vaccine Sales (M Doses) Comparison by Application (2021-2027)

    Table 3. Global Flu Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)

    Table 4. Key Manufacturers Flu Vaccine Covered in This Study

    Table 5. Global Flu Vaccine Sales (M Doses) of Key Manufacturers (2016-2021)

    Table 6. Global Flu Vaccine Sales Market Share by Manufacturers (2016-2021)

    Table 7. Global Flu Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)

    Table 8. Global Flu Vaccine Revenue Share by Manufacturers (2016-2021)

    Table 9. Global Market Flu Vaccine Average Price (US$/Dose) of Key Manufacturers (2016-2021)

    Table 10. Manufacturers Flu Vaccine Manufacturing Sites and Area Served

    Table 11. Manufacturers Flu Vaccine Product Type

    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 13. Global Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flu Vaccine as of 2020)

    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 15. Global Flu Vaccine Sales by Region (2016-2021) & (M Doses)

    Table 16. Global Flu Vaccine Sales Market Share by Region (2016-2021)

    Table 17. Global Flu Vaccine Revenue by Region (2016-2021) & (US$ Million)

    Table 18. North America Flu Vaccine Sales by Country (2016-2021) & (M Doses)

    Table 19. North America Flu Vaccine Sales Market Share by Country (2016-2021)

    Table 20. North America Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)

    Table 21. North America Flu Vaccine Revenue Market Share by Country (2016-2021)

    Table 22. Europe Flu Vaccine Sales by Country (2016-2021) & (M Doses)

    Table 23. Europe Flu Vaccine Sales Market Share by Country (2016-2021)

    Table 24. Europe Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)

    Table 25. Europe Flu Vaccine Revenue Market Share by Country (2016-2021)

    Table 26. Asia Pacific Flu Vaccine Sales by Region (2016-2021) & (M Doses)

    Table 27. Asia Pacific Flu Vaccine Sales Market Share by Region (2016-2021)

    Table 28. Asia Pacific Flu Vaccine Revenue by Region (2016-2021) & (US$ Million)

    Table 29. Asia Pacific Flu Vaccine Revenue Market Share by Region (2016-2021)

    Table 30. Latin America Flu Vaccine Sales by Country (2016-2021) & (M Doses)

    Table 31. Latin America Flu Vaccine Sales Market Share by Country (2016-2021)

    Table 32. Latin America Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)

    Table 33. Latin America Flu Vaccine Revenue Market Share by Country (2016-2021)

    Table 34. Middle East and Africa Flu Vaccine Sales by Country (2016-2021) & (M Doses)

    Table 35. Middle East and Africa Flu Vaccine Sales Market Share by Country (2016-2021)

    Table 36. Middle East and Africa Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)

    Table 37. Middle East and Africa Flu Vaccine Revenue Market Share by Country (2016-2021)

    Table 38. Global Flu Vaccine Sales (M Doses) by Type (2016-2021)

    Table 39. Global Flu Vaccine Sales Market Share by Type (2016-2021)

    Table 40. Global Flu Vaccine Revenue (Million US$) by Type (2016-2021)

    Table 41. Global Flu Vaccine Revenue Share by Type (2016-2021)

    Table 42. Global Flu Vaccine Price (US$/Dose) by Type (2016-2021)

    Table 43. Global Flu Vaccine Sales (M Doses) by Application (2016-2021)

    Table 44. Global Flu Vaccine Sales Market Share by Application (2016-2021)

    Table 45. Global Flu Vaccine Revenue (Million US$) by Application (2016-2021)

    Table 46. Global Flu Vaccine Revenue Share by Application (2016-2021)

    Table 47. Global Flu Vaccine Price (US$/Dose) by Application (2016-2021)

    Table 48. Sanofi Pasteur Corporation Information

    Table 49. Sanofi Pasteur Description and Business Overview

    Table 50. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)

    Table 51. Sanofi Pasteur Flu Vaccine Product

    Table 52. Sanofi Pasteur Recent Developments/Updates

    Table 53. CSL Corporation Information

    Table 54. CSL Description and Business Overview

    Table 55. CSL Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)

    Table 56. CSL Flu Vaccine Product

    Table 57. CSL Recent Developments/Updates

    Table 58. GSK Corporation Information

    Table 59. GSK Description and Business Overview

    Table 60. GSK Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)

    Table 61. GSK Flu Vaccine Product

    Table 62. GSK Recent Developments/Updates

    Table 63. Mylan Corporation Information

    Table 64. Mylan Description and Business Overview

    Table 65. Mylan Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)

    Table 66. Mylan Flu Vaccine Product

    Table 67. Mylan Recent Developments/Updates

    Table 68. Hulan Bio Corporation Information

    Table 69. Hulan Bio Description and Business Overview

    Table 70. Hulan Bio Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)

    Table 71. Hulan Bio Flu Vaccine Product

    Table 72. Hulan Bio Recent Developments/Updates

    Table 73. AstraZeneca Corporation Information

    Table 74. AstraZeneca Description and Business Overview

    Table 75. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)

    Table 76. AstraZeneca Flu Vaccine Product

    Table 77. AstraZeneca Recent Developments/Updates

    Table 78. CCBIO Corporation Information

    Table 79. CCBIO Description and Business Overview

    Table 80. CCBIO Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)

    Table 81. CCBIO Flu Vaccine Product

    Table 82. CCBIO Recent Developments/Updates

    Table 83. Production Base and Market Concentration Rate of Raw Material

    Table 84. Key Suppliers of Raw Materials

    Table 85. Flu Vaccine Distributors List

    Table 86. Flu Vaccine Customers List

    Table 87. Flu Vaccine Market Trends

    Table 88. Flu Vaccine Growth Drivers

    Table 89. Flu Vaccine Market Challenges

    Table 90. Flu Vaccine Market Restraints

    Table 91. Global Flu Vaccine Sales Forecast by Type (2022-2027) & (M Doses)

    Table 92. Global Flu Vaccine Sales Market Share Forecast by Type (2022-2027)

    Table 93. Global Flu Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)

    Table 94. Global Flu Vaccine Revenue Market Share Forecast by Type (2022-2027)

    Table 95. Global Flu Vaccine Sales Forecast by Application (2022-2027) & (M Doses)

    Table 96. Global Flu Vaccine Sales Market Share Forecast by Application (2022-2027)

    Table 97. Global Flu Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)

    Table 98. Global Flu Vaccine Revenue Market Share Forecast by Application (2022-2027)

    Table 99. Global Flu Vaccine Sales Forecast by Region (2022-2027) & (M Doses)

    Table 100. Global Flu Vaccine Sales Market Share Forecast by Region (2022-2027)

    Table 101. Global Flu Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)

    Table 102. Global Flu Vaccine Revenue Market Share Forecast by Region (2022-2027)

    Table 103. Research Programs/Design for This Report

    Table 104. Key Data Information from Secondary Sources

    Table 105. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Flu Vaccine

    Figure 2. Global Flu Vaccine Market Share by Type in 2020 & 2027

    Figure 3. Trivalent Influenza Vaccine Product Picture

    Figure 4. Quadrivalent Influenza Vaccine Product Picture

    Figure 5. Global Flu Vaccine Market Share by Application in 2020 & 2027

    Figure 6. For Children (6 months to 3 years)

    Figure 7. For Adults and Children over 3 years

    Figure 8. Global Flu Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027

    Figure 9. Global Flu Vaccine Market Size 2016-2027 (US$ Million)

    Figure 10. Global Flu Vaccine Sales 2016-2027 (M Doses)

    Figure 11. Global Flu Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027

    Figure 12. Flu Vaccine Sales Share by Manufacturers in 2020

    Figure 13. Global Flu Vaccine Revenue Share by Manufacturers in 2020

    Figure 14. The Global 5 and 10 Largest Flu Vaccine Players: Market Share by Revenue in 2020

    Figure 15. Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021

    Figure 16. Global Flu Vaccine Sales Market Share by Region (2016-2021)

    Figure 17. Global Flu Vaccine Sales Market Share by Region in 2020

    Figure 18. Global Flu Vaccine Revenue Market Share by Region (2016-2021)

    Figure 19. Global Flu Vaccine Revenue Market Share by Region in 2020

    Figure 20. U.S. Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 21. Canada Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 22. Germany Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 23. France Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 24. U.K. Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 25. Italy Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 26. Russia Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 27. China Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 28. Japan Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 29. South Korea Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 30. India Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 31. Australia Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 32. China Taiwan Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 33. Indonesia Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 34. Thailand Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 35. Malaysia Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 36. Mexico Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 37. Brazil Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 38. Argentina Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 39. Turkey Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 40. Saudi Arabia Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 41. UAE Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 42. Sales Market Share of Flu Vaccine by Type (2016-2021)

    Figure 43. Sales Market Share of Flu Vaccine by Application (2016-2021)

    Figure 44. Sales Market Share of Flu Vaccine by Application in 2020

    Figure 45. Revenue Share of Flu Vaccine by Application (2016-2021)

    Figure 46. Revenue Share of Flu Vaccine by Application in 2020

    Figure 47. Manufacturing Cost Structure of Flu Vaccine

    Figure 48. Manufacturing Process Analysis of Flu Vaccine

    Figure 49. Flu Vaccine Industrial Chain Analysis

    Figure 50. Channels of Distribution

    Figure 51. Distributors Profiles

    Figure 52. Bottom-up and Top-down Approaches for This Report

    Figure 53. Data Triangulation

    Figure 54. Key Executives Interviewed